We are live on ! Find out more
SRGA

Surgalign Holdings, Inc. Common Stock

Delisted

SRGA was delisted on the 30th of June, 2023.

109 hedge funds and large institutions have $198M invested in Surgalign Holdings, Inc. Common Stock in 2018 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 36 increasing their positions, 38 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more funds holding in top 10

Funds holding in top 10: 23 (+1)

12% more capital invested

Capital invested by funds: $177M → $198M (+$20.6M)

11% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 9

0% more funds holding

Funds holding: 109109 (0)

5% less repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 38

Holders
109
Holders Change
Holders Change %
0%
% of All Funds
2.5%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
10
Increased
36
Reduced
38
Closed
9
Calls
$86K
Puts
Net Calls
+$86K
Net Calls Change
-$2K
Name Holding Trade Value Shares
Change
Change in
Stake
State Board of Administration of Florida Retirement System
51
State Board of Administration of Florida Retirement System
Florida
$334K
Ameriprise
52
Ameriprise
Minnesota
$323K +$9.12K +67 +3%
TA
53
Teton Advisors
New York
$304K
AllianceBernstein
54
AllianceBernstein
Tennessee
$302K
SRAM
55
Stone Ridge Asset Management
New York
$279K
CAM
56
ClariVest Asset Management
California
$259K +$140K +1,030 +122%
OAM
57
Oxford Asset Management
United Kingdom
$244K -$3.13K -23 -1%
New York State Common Retirement Fund
58
New York State Common Retirement Fund
New York
$240K
Bank of America
59
Bank of America
North Carolina
$237K +$68K +500 +41%
RhumbLine Advisers
60
RhumbLine Advisers
Massachusetts
$231K -$8.85K -65 -4%
PP
61
PDT Partners
New York
$210K -$14.2K -104 -6%
Manulife (Manufacturers Life Insurance)
62
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$209K +$953 +7 +0.5%
JP Morgan Chase
63
JP Morgan Chase
New York
$204K +$134K +988 +204%
LCM
64
Landscape Capital Management
New Jersey
$192K +$25.2K +185 +15%
TRCT
65
Tower Research Capital (TRC)
New York
$191K +$79.1K +581 +72%
SIM
66
Spark Investment Management
New York
$184K -$360K -2,645 -66%
Goldman Sachs
67
Goldman Sachs
New York
$174K +$953 +7 +0.6%
SRC
68
Shufro Rose & Co
New York
$166K -$11.3K -83 -6%
AIG
69
American International Group
New York
$161K -$8.57K -63 -5%
Squarepoint
70
Squarepoint
New York
$158K -$40.1K -295 -21%
SG Americas Securities
71
SG Americas Securities
New York
$157K +$29.5K +217 +24%
WAM
72
Wealthspire Advisors (Maryland)
Maryland
$153K
CCIA
73
Campbell & Co Investment Adviser
Maryland
$152K +$5.04K +37 +3%
MSL
74
Mackay Shields LLC
New York
$151K +$149K +1,093 New
VOYA Investment Management
75
VOYA Investment Management
Georgia
$149K -$21.5K -158 -13%

SRGA Hedge Fund Activity: Q1 2018 in Review

109 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Surgalign Holdings, Inc. Common Stock (SRGA) for Q1 2018, worth a combined $198M — up 12% from $177M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new SRGA positions and 9 closed out — a net gain of 1 holder — while 36 added to existing stakes and 38 trimmed.

The largest buyer was Rutabaga Capital Management, adding an estimated $2.57M. The largest seller was Hillman Company, cutting an estimated $3.06M.

  • 109 institutional investors held Surgalign Holdings, Inc. Common Stock (SRGA) as of Q1 2018, unchanged from Q4 2017.
  • Funds reported $198M of Surgalign Holdings, Inc. Common Stock stock for Q1 2018, up 12% quarter-over-quarter.
  • 10 funds opened new Surgalign Holdings, Inc. Common Stock positions in Q1 2018 and 9 closed out, a net change of +1 holder.
  • The largest Surgalign Holdings, Inc. Common Stock buyer in Q1 2018 was Rutabaga Capital Management, an estimated $2.57M added.
  • The largest Surgalign Holdings, Inc. Common Stock seller in Q1 2018 was Hillman Company, an estimated $3.06M sold.

Based on aggregated 13F filings for Q1 2018.